Wall Street analysts are cautiously optimistic on J&J’s ‘one-dose’ Covid vaccine
Source: CNBC By Julianna Tatelbaum Johnson & Johnson is expected to deliver preliminary late-stage trial results for its one-dose Covid vaccine candidate by the end of January. If its jab […]